Briacell Therapeutics Corp (BCTX)
3.95 x 10 4.55 x 2
Post-market by (Cboe BZX)
3.97 -0.07 (-1.73%) 03/28/25 [NASDAQ]
3.95 x 10 4.55 x 2
Post-market 3.95 -0.02 (-0.50%) 16:21 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
07-2024 | 07-2023 | 07-2022 | 07-2021 | 07-2020 | |
Operating Expenses | 33,330 | 23,272 | 15,289 | 6,976 | 3,939 |
Operating Income | -33,330 | -23,272 | -15,289 | -6,976 | -3,939 |
Interest Expense | 0 | 0 | 1 | 79 | 30 |
Other Income | 28,399 | 2,970 | -11,549 | -6,762 | -56 |
Pre-tax Income | -4,932 | -20,302 | -26,839 | -13,816 | -4,025 |
Net Income Continuous | -4,932 | -20,302 | -26,839 | -13,816 | -4,025 |
Minority Interests | -140 | N/A | N/A | N/A | N/A |
Net Income | $-4,792 | $-20,302 | $-26,839 | $-13,816 | $-4,025 |
EPS Basic Total Ops | -4.35 | -19.49 | -25.94 | -45.88 | -84.56 |
EPS Basic Continuous Ops | -4.49 | -19.49 | -25.97 | -45.83 | -84.52 |
EPS Diluted Total Ops | -4.35 | -19.49 | -25.94 | -45.88 | -84.56 |
EPS Diluted Continuous Ops | -4.49 | -19.49 | -25.97 | -45.83 | -84.52 |
EPS Diluted Before Non-Recurring Items | -4.35 | -19.49 | -25.94 | -1.35 | -77.96 |
EBITDA(a) | $-33,246 | $-23,257 | $-15,274 | $-6,961 | $-3,924 |